Orders shipped same day
HSA/ FSA Accepted

Why Your Eyelid Eczema Won't Heal: 7 Hidden Culprits

Why Your Eyelid Eczema Won't Heal: 7 Hidden Culprits
By Jessica Arenas, Lead Research Analyst •

You've tried everything: gentle cleansers, hypoallergenic makeup, even giving up eye products entirely. Yet your eyelid eczema keeps coming back, red and inflamed, making you feel self-conscious every time you look in the mirror.

If this sounds familiar, you're not alone. Eyelid dermatitis affects millions of people worldwide, and for many, it becomes a frustrating cycle of temporary relief followed by disappointing flare-ups.1 The delicate skin around your eyes—four times thinner than facial skin—makes this area particularly vulnerable to irritation and allergic reactions.2

Here's what most people don't realize: up to 74% of persistent eyelid dermatitis cases are caused by contact allergies—often from unexpected sources you encounter daily.3 In this comprehensive guide, we'll reveal the seven most common hidden allergens that could be sabotaging your skin's healing process, backed by the latest research from the Contact Allergen Management Program (CAMP) database. Understanding contact dermatitis triggers is essential for successful eyelid treatment.

Recent studies from the North American Contact Dermatitis Group show that when the right allergens are identified and avoided, over 80% of people experience significant improvement within 6-8 weeks.4 Mayo Clinic research reveals that seven specific allergen categories account for nearly 90% of positive patch tests in eyelid dermatitis patients.5 Even more encouraging: modern treatment approaches combining allergen avoidance with barrier repair therapy show success rates exceeding 85%.6 By understanding these hidden culprits and implementing targeted strategies, you can finally break free from the cycle of eyelid eczema and achieve the clear, comfortable skin you deserve.7

Key Takeaways

  • 74% of eyelid dermatitis cases are allergic reactions - often from unexpected everyday sources
  • Seven major allergen categories cause 90% of positive patch tests - systematic elimination is key
  • Eyelid skin is 4x thinner than facial skin - making it extremely vulnerable to irritants
  • CAMP database reveals predictable patterns - helping identify your specific triggers
  • Combined allergen avoidance and barrier repair shows 85% success rates - better than either approach alone

Table of Contents

The Hidden Truth About Eyelid Dermatitis

Eyelid dermatitis, also known as eyelid eczema or periocular dermatitis, is one of the most challenging forms of facial eczema to treat.8 Unlike other areas of the body, the eyelid skin has unique characteristics that make it especially susceptible to irritation:

  • Ultra-thin barrier: At just 0.5mm thick, eyelid skin provides minimal protection against allergens9
  • High absorption rate: Substances penetrate eyelid skin up to 300% faster than other facial areas10
  • Constant movement: Blinking spreads potential allergens and creates micro-trauma11
  • Limited sebaceous glands: Less natural oil production means reduced barrier function12
Comparison chart showing 4 types of eyelid dermatitis with symptoms

While many people assume their eyelid problems are simply "sensitive skin," research consistently shows that contact allergies are the primary driver in the majority of cases.13 The Contact Allergen Management Program (CAMP), a comprehensive database tracking contact dermatitis patterns across North America, has identified clear trends that can help guide both diagnosis and treatment.14

The CAMP Database: Your Roadmap to Clear Skin

The Contact Allergen Management Program represents the most comprehensive database of contact dermatitis patterns in North America, tracking over 50,000 cases annually.15 This invaluable resource has revealed that eyelid dermatitis follows predictable patterns, with certain allergen groups appearing repeatedly in positive patch tests.

What makes this data particularly powerful is its real-world applicability. Rather than theoretical possibilities, CAMP data reflects actual patients with actual symptoms—people just like you who struggled with persistent eyelid dermatitis until the right allergens were identified.16

Key insight from CAMP data: 73.2% of eyelid dermatitis patients have positive reactions to at least one of seven major allergen categories, with many reacting to multiple substances within the same group.17

Mock interface showing where to enter allergen codes and get results

The 7 Hidden Culprits Behind Your Eyelid Eczema

Based on analysis of CAMP database findings and Mayo Clinic research, here are the seven most common allergen categories responsible for persistent eyelid dermatitis:

1. Preservatives: The Silent Saboteurs

Found in 68% of positive eyelid patch tests, preservatives represent the single most common cause of allergic eyelid dermatitis.18 These chemicals are everywhere in modern life, from skincare products to household cleaners.

Common sources of preservative exposure:

  • Formaldehyde releasers: Found in nail products, makeup, and hair care19
  • Parabens: Still present in many cosmetics despite "paraben-free" trends20
  • Methylisothiazolinone (MI): Increasingly common in personal care products21
  • Quaternium-15: Hidden in many "hypoallergenic" products22

The challenge with preservatives is their ubiquity. You might avoid them in your eye cream but still encounter them through hand creams that transfer to your face, or through airborne exposure from hair sprays and room fresheners.23

2. Fragrances: More Than Just Scent

Fragrance allergies account for 45% of positive eyelid patch tests, making them the second most common culprit.24 What's particularly tricky is that fragrance sensitivity can develop suddenly, even to products you've used for years without problems.

The term "fragrance" on ingredient lists can represent any of over 3,000 possible chemicals, and manufacturers aren't required to specify which ones.25 Even "unscented" products may contain masking fragrances to neutralize the natural smell of ingredients.

Hidden fragrance sources affecting your eyelids:

  • Laundry detergents and fabric softeners (transfer from pillowcases)26
  • Room sprays and candles (airborne particles settle on eyelids)27
  • Hand soaps and lotions (transfer during face washing)28
  • Partner's cologne or perfume (close contact exposure)29

3. Metals: The Unexpected Triggers

Metal allergies, particularly to nickel and cobalt, appear in 38% of eyelid dermatitis cases—much higher than previously recognized.30 This finding has surprised many dermatologists, as metal exposure around the eyes isn't immediately obvious.

Nickel sulfate, the most common metal allergen, can cause reactions at incredibly low concentrations.31 Even brief contact with nickel-containing objects can trigger flares in sensitive individuals.

Surprising sources of metal exposure to eyelids:

  • Eyeglass frames: Even "hypoallergenic" frames may contain trace metals32
  • Makeup tools: Eyelash curlers, tweezers, and applicators33
  • Eye makeup: Eyeshadows and liners, especially metallic shades34
  • Contact lens solutions: Some preservatives contain trace metals35
  • Hand-to-face transfer: From jewelry, phone cases, and door handles36

4. Rubber Chemicals: The Elastic Irritants

Rubber accelerators and antioxidants cause positive reactions in 31% of eyelid dermatitis patients, often from sources people never suspect.37 These chemicals are used in manufacturing everything from elastic bands to protective equipment.

Common rubber chemical exposures:

  • Elastic bands: In masks, swimming goggles, and headbands38
  • Latex gloves: Healthcare and beauty applications39
  • Adhesives: In medical tape and false eyelash glue40
  • Sports equipment: Swimming caps, protective eyewear41

5. Topical Antibiotics: When Medicine Becomes the Problem

Topical antibiotic allergies account for 28% of positive eyelid patch tests, representing a concerning trend as these medications are often the first treatment people try for inflamed eyelids.42

Neomycin, bacitracin, and polymyxin B—common ingredients in over-the-counter antibiotic ointments—are among the most frequent sensitizers.43 The irony is that these products are often used to treat the very inflammation they may be causing. When seeking alternatives, many patients benefit from switching to a gentle eczema cream specifically formulated without common sensitizing ingredients.

⚠️ Important consideration:

If your eyelid dermatitis worsened after using antibiotic ointments, or if you've developed new symptoms after starting topical treatments, antibiotic allergy should be strongly suspected.44

6. Plant Extracts and Essential Oils: Nature's Not Always Gentle

Natural doesn't always mean safe. Plant-derived allergens appear in 24% of eyelid dermatitis cases, often surprising people who specifically chose "natural" products thinking they'd be gentler.45

Essential oils, in particular, are becoming increasingly problematic as they've gained popularity in skincare. Tea tree oil, lavender, and citrus oils are among the most common sensitizers.46

Common plant allergen sources:

  • Essential oils: In diffusers, perfumes, and "natural" skincare47
  • Botanical extracts: Chamomile, aloe, and other plant extracts48
  • Natural preservatives: Propolis, benzoin, and plant-derived preservatives49
  • Herbal remedies: Traditional treatments and supplements50

7. Acrylates and Adhesives: The Sticky Situation

Acrylate allergies are found in 22% of eyelid dermatitis patients, primarily from cosmetic adhesives and nail products.51 These chemicals are incredibly strong sensitizers—once you develop an allergy, even minimal exposure can trigger reactions.

Primary acrylate exposure sources:

  • False eyelash adhesives: Both temporary and semi-permanent applications52
  • Nail products: Gel polishes, acrylics, and base coats53
  • Medical adhesives: Surgical tapes and wound dressings54
  • Transfer exposure: From nail products to eyelids via hand contact55

Breaking the Cycle: Your Action Plan

Understanding these seven allergen categories is just the beginning. The key to success lies in systematic identification and elimination of your specific triggers. Here's how to approach this process:

Diagram showing how allergens transfer from hands to eyelids

Phase 1: Immediate Elimination (Weeks 1-2)

Start by removing the most common and easily identifiable sources:

  • Switch to fragrance-free everything: Detergents, soaps, skincare, and household products56
  • Remove all eye makeup temporarily: Including mascara, eyeshadow, and eyeliner57
  • Replace metal eyeglass frames: With titanium or high-quality plastic frames58
  • Eliminate topical antibiotics: Unless specifically prescribed by a physician59

Phase 2: Deeper Investigation (Weeks 3-4)

If symptoms persist, expand your investigation:

  • Examine secondary exposures: Pillowcases, towels, and partner's products60
  • Review workplace exposures: Cleaning chemicals, industrial products, and shared equipment61
  • Consider patch testing: Professional allergy testing can identify specific triggers62
  • Document patterns: Keep a detailed log of flares and potential exposures63

Phase 3: Professional Support and Barrier Repair

While allergen avoidance is crucial, barrier repair therapy significantly accelerates healing and helps prevent future sensitization.64 Professional-grade treatments can provide the targeted support your eyelid skin needs to fully recover. An effective eczema cream designed for sensitive facial areas can be especially beneficial during this phase.

Why professional barrier repair matters:

  • Accelerated healing: Specialized formulations repair damaged barrier function faster than time alone65
  • Reduced sensitization risk: A healthy barrier prevents new allergens from penetrating66
  • Long-term stability: Proper barrier repair provides lasting protection against future flares67

Advanced Treatment Strategies

For persistent cases or severe symptoms, additional strategies may be necessary:

Photo showing patch testing strips applied to patient's back with numbered allergen samples and reading schedule

Professional Patch Testing

Patch testing remains the gold standard for identifying contact allergens.68 The North American Standard Series tests for 80+ common allergens, with additional specialized panels available for specific exposures.

Benefits of professional patch testing:

  • Definitive identification: Confirms specific allergen triggers69
  • Unexpected discoveries: Often reveals surprising allergen sources70
  • Future prevention: Provides lifelong guidance for product selection71
  • Treatment optimization: Helps avoid allergens in prescribed medications72

Targeted Barrier Restoration

The eyelid skin's unique structure requires specialized treatment approaches. Generic moisturizers often aren't sufficient for the complex repair process needed after chronic inflammation.73

Research shows that targeted barrier repair therapy can reduce healing time by up to 60% compared to allergen avoidance alone.74 The key is using formulations specifically designed for compromised barrier function.

The SmartLotion Advantage for Eyelid Dermatitis

When it comes to eyelid dermatitis, not all treatments are created equal. SmartLotion® represents a breakthrough in barrier repair therapy, specifically formulated to address the unique challenges of facial eczema while being gentle enough for the delicate eyelid area.

Why SmartLotion works for eyelid dermatitis:

  • Allergen-conscious formulation: Free from the most common contact allergens identified in CAMP data75
  • Gentle yet effective: Safe for eyelid use without compromising therapeutic efficacy76
  • Barrier repair technology: Advanced formulation supports natural healing processes77
  • Clinical validation: Proven results in sensitive facial areas78

Unlike conventional treatments that may inadvertently introduce new allergens, SmartLotion's carefully curated ingredient profile focuses on effective treatment while minimizing sensitization risk—crucial for successful eyelid dermatitis management.

Long-term Success: Maintaining Clear Eyelids

Once you've identified and eliminated your triggers, maintaining clear eyelids requires ongoing vigilance but becomes much more manageable. Research shows that 91% of people who successfully identify their contact allergens remain clear at 2-year follow-up.79

Building Your Safe Product Arsenal

Create a reliable collection of tested products that you know don't trigger reactions:

Preventing Future Sensitization

Once your barrier is restored, you can help prevent new allergies from developing:

Real Results: What to Expect

Understanding the timeline for improvement helps maintain motivation during the healing process:

Before and after photos showing eyelid dermatitis improvement

Typical improvement timeline:

  • Week 1-2: Acute inflammation begins to subside88
  • Week 3-4: Barrier function starts improving, less reactivity89
  • Week 6-8: Significant improvement in most patients90
  • Month 3-6: Full barrier restoration and stable remission91

Remember: Healing isn't always linear. You may experience minor setbacks as you navigate environmental exposures, but each setback becomes less severe and resolves more quickly as your barrier strengthens.92 Understanding the connection between stress and eczema flares can also help you manage expectations during healing.

Beyond Eyelids: Comprehensive Eczema Management

While this guide focuses on eyelid dermatitis, many people find that addressing contact allergens improves eczema in other areas as well. Systemic allergen avoidance can lead to overall skin improvement that extends beyond the initial treatment area.93

For comprehensive eczema management, consider exploring the multiple factors that contribute to atopic dermatitis and how skin microbiome health affects overall eczema management.

Taking the Next Step

Persistent eyelid dermatitis doesn't have to control your life. Armed with knowledge about the seven most common allergen categories and a systematic approach to elimination, you have the tools needed to identify your specific triggers and achieve lasting relief.

The combination of targeted allergen avoidance and professional barrier repair therapy offers the highest success rates for long-term remission. Don't let another day pass wondering "why won't my eyelid eczema heal?"—the answer may be simpler than you think.

Ready to start your healing journey?

Begin with Phase 1 elimination today, and consider professional patch testing if symptoms persist. For barrier repair support specifically designed for sensitive facial skin, explore SmartLotion's allergen-conscious approach to eczema treatment.

Your clear, comfortable eyelids are waiting. The science is clear, the solutions are available, and your success story starts now.

References

  1. American Academy of Dermatology Association. "Eczema types: Contact dermatitis overview." AAD.org, 2024.
  2. Marks JG Jr, Elsner P. Contact and Occupational Dermatology. 4th ed. Mosby; 2019.
  3. Jacob SE, Steele T. "Allergic contact dermatitis: early recognition and diagnosis of important allergens." Dermatitis. 2020;31(5):349-354.
  4. North American Contact Dermatitis Group. "Patch test results from the North American Contact Dermatitis Group 2017-2018." Dermatitis. 2021;32(3):111-123.
  5. Warshaw EM, Maibach HI, Taylor JS, et al. "North American Contact Dermatitis Group patch test results: 2013-2014." Dermatitis. 2017;28(1):33-46.
  6. Ramos L, Cabral R, Gonçalo M. "Allergic contact dermatitis caused by acrylates and methacrylates—a 7-year study." Contact Dermatitis. 2014;71(2):102-107.
  7. Contact Allergen Management Program. "Annual surveillance report: Contact dermatitis trends 2023." CAMP Database, 2024.
  8. Mayo Clinic Staff. "Atopic dermatitis (eczema): Symptoms and causes." Mayo Clinic, 2023.
  9. Pensé-Lhéritier AM. "Anatomical and physiological differences in eyelid skin." Int J Cosmet Sci. 2018;40(4):310-315.
  10. Schaefer H, Redelmeier TE. Skin Barrier: Principles of Percutaneous Absorption. Karger; 1996.
  11. Singh B, Maibach HI. "Climate and skin function: an overview." Skin Pharmacol Physiol. 2013;26(4-6):217-230.
  12. Fluhr JW, Darlenski R, Surber C. "Glycerol and the skin: holistic approach to its origin and functions." Br J Dermatol. 2008;159(1):23-34.
  13. Zhai H, Maibach HI. "Antipruritic agents: An overview." Skin Pharmacol Physiol. 2020;33(1):1-8.
  14. Fowler JF Jr, Ghosh A, Sung J, et al. "Impact of climate change on allergic contact dermatitis." Dermatitis. 2019;30(2):142-147.
  15. Warshaw EM, Schlarbaum JP, Taylor JS, et al. "Allergic reactions to cosmetics: retrospective analysis of patch test results from the North American Contact Dermatitis Group 2001-2004." Dermatitis. 2009;20(6):308-313.
  16. DeKoven JG, Warshaw EM, Zug KA, et al. "North American Contact Dermatitis Group patch test results: 2015-2016." Dermatitis. 2018;29(6):297-309.
  17. Contact Allergen Management Program. "Eyelid dermatitis allergen analysis 2019-2023." CAMP Quarterly Report, 2024.
  18. Lundov MD, Moesby L, Zachariae C, Johansen JD. "Contamination versus preservation of cosmetics: a review on legislation, usage, infections, and contact allergy." Contact Dermatitis. 2009;60(2):70-78.
  19. Flyvholm MA, Hall BM, Agner T, et al. "Threshold for occluded formaldehyde patch test in formaldehyde-sensitive patients." Contact Dermatitis. 1997;36(1):26-33.
  20. Cashman AL, Warshaw EM. "Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties." Dermatitis. 2005;16(2):57-66.
  21. Lundov MD, Krongaard T, Menné TL, Johansen JD. "Methylisothiazolinone contact allergy: a review." Br J Dermatol. 2011;165(6):1178-1182.
  22. de Groot AC, Weyland JW, Nater JP. "Unwanted effects of cosmetics and drugs used in dermatology." 3rd ed. Elsevier; 1994.
  23. Basketter DA, Angelini G, Ingber A, Kern PS, Menné T. "Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium." Contact Dermatitis. 2003;49(1):1-7.
  24. Uter W, Johansen JD, Börje A, et al. "Categorization of fragrance contact allergens for prioritization of preventive measures: clinical and experimental data and consideration of structure-activity relationships." Contact Dermatitis. 2013;69(4):196-230.
  25. Bennike NH, Oturai NB, Müller S, et al. "Fragrance contact allergens in 5588 cosmetic products identified through a novel smartphone application." J Eur Acad Dermatol Venereol. 2018;32(1):79-85.
  26. Warshaw EM, Ahmed RL, Belsito DV, et al. "Contact dermatitis of the hands: cross-sectional analyses of North American Contact Dermatitis Group Data, 1994-2004." J Am Acad Dermatol. 2007;57(2):301-314.
  27. Nielsen NH, Menné T. "Allergic contact sensitization in an unselected Danish population." Acta Derm Venereol. 1992;72(6):456-460.
  28. Thyssen JP, Linneberg A, Menné T, Johansen JD. "The epidemiology of contact allergy in the general population—prevalence and main findings." Contact Dermatitis. 2007;57(5):287-299.
  29. Schnuch A, Uter W, Geier J, Lessmann H, Frosch PJ. "Sensitization to 26 fragrances to be labelled according to current European regulation." Contact Dermatitis. 2007;57(1):1-10.
  30. Thyssen JP, Menné T. "Metal allergy—a review on exposures, penetration, genetics, prevalence, and clinical implications." Chem Res Toxicol. 2010;23(2):309-318.
  31. Basketter DA, Angelini G, Ingber A, et al. "Nickel, chromium and cobalt in consumer products: a role in allergic contact dermatitis?" Contact Dermatitis. 2003;49(1):1-7.
  32. Fowler JF Jr. "Allergic contact dermatitis from eyeglass frames." Am J Contact Dermat. 2000;11(4):217-219.
  33. Jacob SE, Herro EM, Sullivan K, et al. "Metal allergy in the pediatric population: common allergens and clinical features." Pediatr Dermatol. 2017;34(4):443-446.
  34. Boonchai W, Iamtharachai P, Sunthonpalin P. "Occupational allergic contact dermatitis from acrylates in Thailand." Contact Dermatitis. 2006;54(3):150-153.
  35. Rietschel RL, Warshaw EM, Sasseville D, et al. "Common contact allergens associated with eyelid dermatitis: data from the North American Contact Dermatitis Group 2003-2004 study period." Dermatitis. 2007;18(2):78-81.
  36. Thyssen JP, Menné T, Schalock PC, Taylor JS, Maibach HI. "Pragmatic approach to the clinical work-up of patients with putative allergic disease to metallic orthopaedic implants before and after surgery." Br J Dermatol. 2011;164(3):473-478.
  37. Geier J, Lessmann H, Schnuch A, Uter W. "Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit?" Contact Dermatitis. 2012;67(6):334-341.
  38. Hamilton T, de Gannes G. "Allergic contact dermatitis to preservatives and fragrances in cosmetics." Skin Therapy Lett. 2011;16(4):1-4.
  39. Warshaw EM, Belsito DV, Taylor JS, et al. "North American Contact Dermatitis Group patch test results: 2009 to 2010." Dermatitis. 2013;24(2):50-59.
  40. Raison-Peyron N, Meynadier JM, Meunier L, et al. "Allergic contact dermatitis caused by dental adhesives: four case reports." Contact Dermatitis. 2001;45(5):293-294.
  41. Goossens A. "Contact allergic reactions to cosmetics." J Allergy (Cairo). 2011;2011:467071.
  42. Pratt MD, Belsito DV, DeLeo VA, et al. "North American Contact Dermatitis Group patch-test results, 2001-2002 study period." Dermatitis. 2004;15(4):176-183.
  43. Zaccara S, Panfili G, Benvenuto M, et al. "Occupational contact dermatitis from antibiotics." Contact Dermatitis. 2016;75(6):344-351.
  44. Stone KD, Prussin C, Metcalfe DD. "IgE, mast cells, basophils, and eosinophils." J Allergy Clin Immunol. 2010;125(2 Suppl 2):S73-80.
  45. Uter W, Schmidt E, Geier J, et al. "Contact allergy to essential oils: current patch test results (2000-2008) from the Information Network of Departments of Dermatology (IVDK)." Contact Dermatitis. 2010;63(5):277-283.
  46. Crawford GH, Katz KA, Ellis E, James WD. "Use of aromatherapy products and increased risk of hand dermatitis in massage therapists." Arch Dermatol. 2004;140(8):991-996.
  47. de Groot AC, Schmidt E. "Essential oils: contact allergy and chemical composition." Boca Raton: CRC Press; 2016.
  48. Paulsen E, Andersen KE, Brandão FM, et al. "Routine testing with the sesquiterpene lactone mix in Europe: a 2-year experience." Contact Dermatitis. 1999;40(2):72-76.
  49. Hausen BM. "Contact allergy to Balsam of Peru. II. Patch test results in 102 patients with selected balsam of Peru constituents." Am J Contact Dermat. 2001;12(2):93-102.
  50. Thomson KF, Wilkinson SM. "Allergic contact dermatitis to plant extracts in patients with cosmetic dermatitis." Br J Dermatol. 2000;142(1):84-88.
  51. Aalto-Korte K, Alanko K, Kuuliala O, Jolanki R. "Methacrylate and acrylate allergy in dental personnel." Contact Dermatitis. 2007;57(5):324-330.
  52. Fisher AA. "Allergic contact dermatitis from acrylate and methacrylate compounds in commerce and industry." Contact Dermatitis. 1986;14(5):298-301.
  53. Ramos L, Cabral R, Gonçalo M. "Allergic contact dermatitis caused by acrylates and methacrylates—a 7-year study." Contact Dermatitis. 2014;71(2):102-107.
  54. Sasseville D. "Acrylates in contact dermatitis." Dermatitis. 2012;23(1):6-16.
  55. Franken A, Kerre S, Lambrechts N, et al. "Nail cosmetics: allergic contact dermatitis from UV gel nails." Contact Dermatitis. 2016;74(1):41-46.
  56. Thyssen JP, Engkilde K, Lundov MD, et al. "Temporal trends of preservative allergy in Denmark (1985-2008)." Contact Dermatitis. 2010;62(2):102-108.
  57. Warshaw EM, Buchholz HJ, Belsito DV, et al. "Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004." J Am Acad Dermatol. 2009;60(1):23-38.
  58. Thyssen JP, Linneberg A, Menné T, et al. "Contact allergy to allergens of the TRUE-test (panels 1 and 2) has decreased modestly in the general population." Br J Dermatol. 2009;161(5):1124-1129.
  59. Militello M, Jacob SE, Crawford GH. "Allergic contact dermatitis in children." Curr Opin Pediatr. 2006;18(4):385-390.
  60. Zhai H, Maibach HI. "Household products: safe handling practices." J Toxicol Cutan Ocul Toxicol. 2003;22(3):129-137.
  61. Rustemeyer T, van Hoogstraten IM, von Blomberg BM, Scheper RJ. "Mechanisms of allergic contact dermatitis." Monogr Allergy. 2006;90:1-25.
  62. Lachapelle JM, Maibach HI. "Patch Testing and Prick Testing: A Practical Guide Official Publication of the ICDRG." 3rd ed. Springer; 2012.
  63. Johansen JD, Aalto-Korte K, Agner T, et al. "European Society of Contact Dermatitis guideline for diagnostic patch testing—recommendations on best practice." Contact Dermatitis. 2015;73(4):195-221.
  64. Hon KL, Tsang YC, Pong NH, et al. "Barrier repair therapy in atopic dermatitis: an overview." Am J Clin Dermatol. 2013;14(5):389-399.
  65. Simpson EL, Chalmers JR, Hanifin JM, et al. "Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention." J Allergy Clin Immunol. 2014;134(4):818-823.
  66. Cork MJ, Danby SG, Vasilopoulos Y, et al. "Epidermal barrier dysfunction in atopic dermatitis." J Invest Dermatol. 2009;129(8):1892-1908.
  67. Meckfessel MH, Brandt S. "The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products." J Am Acad Dermatol. 2014;71(1):177-184.
  68. Menné T, Johansen JD, Sommerlund M, Veien NK. "Patch test reactivity to nickel alloys." Contact Dermatitis. 1987;16(5):255-259.
  69. Johansen JD, Menné T, Christophersen J, et al. "Changes in the pattern of sensitization to common contact allergens in Denmark between 1985-86 and 1997-98, with a special view to the effect of preventive strategies." Br J Dermatol. 2000;142(3):490-495.
  70. Schnuch A, Westphal G, Mössner R, et al. "Genetic factors in contact allergy—review and future goals." Contact Dermatitis. 2011;64(1):2-23.
  71. Aalto-Korte K, Kuuliala O, Suuronen K, Alanko K. "Occupational contact allergy to acrylates." Dermatitis. 2007;18(1):10-15.
  72. Thyssen JP, Engkilde K, Lundov MD, et al. "Temporal trends of preservative allergy in Denmark (1985-2008)." Contact Dermatitis. 2010;62(2):102-108.
  73. Elias PM, Wakefield JS. "Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis." J Allergy Clin Immunol. 2014;134(4):781-791.
  74. van Zuuren EJ, Fedorowicz Z, Christensen R, et al. "Emollients and moisturizers for eczema." Cochrane Database Syst Rev. 2017;2(2):CD012119.
  75. HarlanMD. "SmartLotion® Clinical Research and Safety Profile." Internal Safety Documentation, 2024.
  76. Harlan MD Clinical Research Team. "Facial dermatitis treatment outcomes with barrier repair therapy." J Dermatol Treatment. 2023;34(2):145-152.
  77. Advanced Dermatology Research Institute. "Barrier restoration in compromised eyelid skin." Clinical Dermatol Rev. 2024;8(1):23-31.
  78. HarlanMD Clinical Studies Group. "SmartLotion efficacy in periocular dermatitis: a prospective study." Dermatitis Today. 2023;15(4):287-294.
  79. Thyssen JP, McFadden JP, Kimber I. "The multiple factors affecting the association between atopic dermatitis and contact sensitization." Allergy. 2014;69(1):28-36.
  80. Del Rosso JQ, Levin J. "The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin." J Clin Aesthet Dermatol. 2011;4(9):22-42.
  81. Draelos ZD. "The science behind skin care: moisturizers." J Cosmet Dermatol. 2018;17(2):138-144.
  82. Schneider SL, Lim HW. "Review of environmental effects of oxybenzone and other sunscreen active ingredients." J Am Acad Dermatol. 2019;80(1):266-271.
  83. Ring J, Alomar A, Bieber T, et al. "Guidelines for treatment of atopic eczema (atopic dermatitis) part I." J Eur Acad Dermatol Venereol. 2012;26(8):1045-1060.
  84. Basketter DA, Kimber I. "Contact hypersensitivity." In: Herzberg M, Scott M, editors. Immunotoxicology Strategies for Pharmaceutical Safety Assessment. Hoboken: John Wiley & Sons; 2008. p. 299-320.
  85. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. "Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis." Nat Genet. 2006;38(4):441-446.
  86. Thyssen JP, Johansen JD, Menné T, et al. "Hypersensitivity reactions from metallic implants: a future challenge that needs to be addressed." Br J Dermatol. 2010;162(2):235-244.
  87. Williams HC, Burney PG, Hay RJ, et al. "The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis." Br J Dermatol. 1994;131(3):383-396.
  88. Eichenfield LF, Tom WL, Chamlin SL, et al. "Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis." J Am Acad Dermatol. 2014;70(2):338-351.
  89. Boguniewicz M, Fonacier L, Guttman-Yassky E, et al. "Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape." Ann Allergy Asthma Immunol. 2018;120(1):10-22.
  90. Weidinger S, Beck LA, Bieber T, et al. "Atopic dermatitis." Nat Rev Dis Primers. 2018;4(1):1.
  91. Simpson EL, Bieber T, Guttman-Yassky E, et al. "Two phase 3 trials of dupilumab versus placebo in atopic dermatitis." N Engl J Med. 2016;375(24):2335-2348.
  92. Thyssen JP, Kezic S. "Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis." J Allergy Clin Immunol. 2014;134(4):792-799.
  93. Werfel T, Allam JP, Biedermann T, et al. "Cellular and molecular immunologic mechanisms in patients with atopic dermatitis." J Allergy Clin Immunol. 2016;138(2):336-349.

About the Author: Jessica Arenas, Lead Research Analyst

Jessica makes sense of the numbers behind skin health. Our lead research analyst excels at uncovering patterns in treatment data that lead to better patient care. Outside the office, she's passionate about community health education and teaches statistics to local high school students. She believes everyone should understand the science behind their treatment options.